Zepbound

• Biden proposes coverage for weight-loss drugs for millions of obese Americans

  While the rule would give millions of people access to weekly injectables that have helped people shed pounds, it would cost taxpayers as much as $35 billion over the next decade.

  Health

  Nov 26, 2024
  
• Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds

  The three-year study of tirzepatide found adults with prediabetes and obesity or overweight taking the drug weekly saw the risk of progression to diabetes lower by 94 per cent.

  Health

  Aug 20, 2024
  
• Advertisement
• What is Zepbound? Could the weight-loss drug work better than Ozempic?

  Zepbound has been approved in the U.S. for weight loss, and studies show it could be the best-performing obesity drug to date.

  Health

  Nov 10, 2023